Glyburide/Metformin (Glucovance) for Type 2 Diabetes
A fixed-dose combination of two antihyperglycemic drugs, glyburide and metformin, has been approved by the US FDA for initial treatment of type 2 diabetes or when glucose control is unsatisfactory with either drug alone...
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Glyburide/Metformin (Glucovance) for Type 2 Diabetes
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1092
Article Code: 1092a
Date: November 13, 2000
Volume: 42
Pages: 105-106
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1092
Article Code: 1092a
Date: November 13, 2000
Volume: 42
Pages: 105-106
Add this downloadable, electronic article to your cart (U.S. English version only) Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.